LOINC parts

72,372 parts · page 1126 of 1,448 · all codes

PartNameTypeTests
LP434175-8 MDS v3.0 - RAI v1.18.11 - Identification Information COMPONENT 1
LP434176-6 MDS v3.0 - RAI v1.18.11 - Hearing, Speech, and Vision COMPONENT 1
LP434177-4 MDS v3.0 - RAI v1.18.11 - Cognitive Patterns COMPONENT 1
LP434178-2 MDS v3.0 - RAI v1.18.11 - Mood COMPONENT 1
LP434179-0 MDS v3.0 - RAI v1.18.11 - Behavior COMPONENT 1
LP434180-8 MDS v3.0 - RAI v1.18.11 - Preferences for Customary Routine and Activities COMPONENT 1
LP434181-6 MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals COMPONENT 1
LP434182-4 MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Admission COMPONENT 1
LP434183-2 MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - Discharge COMPONENT 1
LP434184-0 MDS v3.0 - RAI v1.18.11 - Functional Abilities and Goals - OBRA/Interim COMPONENT 1
LP434187-3 MDS v3.0 - RAI v1.18.11 - Bladder and Bowel COMPONENT 1
LP434188-1 MDS v3.0 - RAI v1.18.11 - Active Diagnoses COMPONENT 1
LP434189-9 MDS v3.0 - RAI v1.18.11 - Health Conditions COMPONENT 1
LP434190-7 MDS v3.0 - RAI v1.18.11 - Swallowing/Nutritional Status COMPONENT 1
LP434191-5 MDS v3.0 - RAI v1.18.11 - Oral/Dental Status COMPONENT 1
LP434192-3 MDS v3.0 - RAI v1.18.11 - Skin Conditions COMPONENT 1
LP434193-1 MDS v3.0 - RAI v1.18.11 - Medications COMPONENT 1
LP434194-9 MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs COMPONENT 1
LP434195-6 MDS v3.0 - RAI v1.18.11 - Restraints and Alarms COMPONENT 1
LP434196-4 MDS v3.0 - RAI v1.18.11 - Participation in Assessment and Goal Setting COMPONENT 1
LP434197-2 MDS v3.0 - RAI v1.18.11 - Care Area Assessment (CAA) Summary COMPONENT 1
LP434198-0 MDS v3.0 - RAI v1.18.11 - Correction Request COMPONENT 1
LP434199-8 MDS v3.0 - RAI v1.18.11 - Assessment Administration COMPONENT 1
LP434214-5 Cardioversion report COMPONENT 1
LP434215-2 Cardiac device monitoring report COMPONENT 1
LP434216-0 Multisection transthoracic limited COMPONENT 1
LP434218-6 Multisection transthoracic limited for congenital disease COMPONENT 1
LP434219-4 Multisection transthoracic for congenital disease COMPONENT 1
LP434224-4 US.2D.A2C+Estimated METHOD 3
LP434244-2 US.2D.A3C+Estimated METHOD 3
LP434245-9 US.2D.A2C+Calculated by biplane area-length method METHOD 1
LP434246-7 Self-Care - Admission Performance COMPONENT 1
LP434247-5 Self-Care - Discharge Goal COMPONENT 1
LP434251-7 Mobility - Admission Performance COMPONENT 1
LP434252-5 Mobility - Discharge Goal COMPONENT 1
LP434253-3 Tub and or shower transfer - functional goal COMPONENT 1
LP434258-2 Aeromonas sp DNA COMPONENT 1
LP434265-7 Nutritional approaches - on admission COMPONENT 1
LP434266-5 Nutritional approaches - at discharge COMPONENT 1
LP434267-3 Participation in assessment and goal setting COMPONENT 2
LP434271-5 Number of venous and arterial ulcers COMPONENT 1
LP434273-1 Reason referral to local contact agency not made COMPONENT 1
LP434275-6 Erythrocytes.Plasmodium falciparum infected COMPONENT
LP434283-0 Wr^b Ag COMPONENT 1
LP434290-5 Natural cannabinoids panel COMPONENT 1
LP434291-3 Epidermal Allergen Mix Dog dander+Cat epithelium+Horse dander COMPONENT
LP434293-9 Epidermal Allergen Mix (Dog dander+Cat epithelium+Horse dander) Ab.IgE panel COMPONENT 1
LP434305-1 Treatment preferences under certain health conditions COMPONENT 1
LP434306-9 AP-3 complex COMPONENT
LP434308-5 AP-3 complex Ab COMPONENT 1

← prev · next →